Impact of Glucagon-Like Peptide-1 Receptor Agonists on Mental Health: A Systematic Review of Psychiatric Safety and Antidepressant Potential. [PDF]
Quadir A +5 more
europepmc +1 more source
The emerging role of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: Therapeutic potential and challenges. [PDF]
Thandampallayam M +3 more
europepmc +1 more source
Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study. [PDF]
Keshen A +44 more
europepmc +1 more source
High Prevalence and Low Incidence of Constipation Among Glucagon-Like Peptide-1 Receptor Agonist Users. [PDF]
Chang M +3 more
europepmc +1 more source
A systematic review and meta-analyses of glucagon-like peptide-1 receptor agonists in acute myocardial infarction. [PDF]
Bhullar JK, Bahekar A.
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists Inhibit the Initiation of Toxic Amyloid-β42 Aggregation. [PDF]
Fallot LB +12 more
europepmc +1 more source
WITHDRAWN: Can glucagon like peptide-1 receptor agonists be beneficial for brain health?
Ballabio G +5 more
europepmc +1 more source

